Objective-Leukocyte recruitment is a major contributor in the development of atherosclerosis and requires a variety of proteins such as adhesion molecules, chemokines, and chemokine receptors. Several key molecular players implicated in this process are expressed on monocytes and require protein-tyrosine sulfation for optimal function in vitro, including human CCR2, CCR5, CX3CR1, and PSGL-1. We therefore hypothesized that protein-tyrosine sulfation in hematopoietic cells plays an important role in the development of atherosclerosis.
See accompanying article on page 1709
Much of the data recognizing the importance of tyrosine sulfation in protein function has been obtained from in vitro studies. [3] [4] [5] [6] [7] Evidence for the importance of tyrosine sulfation in vivo is very limited. Thus, we developed Tpst1 Ϫ/Ϫ ,
Tpst2
Ϫ/Ϫ and Tpst1 Ϫ/Ϫ ; Tpst2 Ϫ/Ϫ double knockout (Tpst DKO) mice. 8 -10 Our studies revealed that both Tpst1 Ϫ/Ϫ and Tpst2 Ϫ/Ϫ mice are viable and have distinct phenotypes. In part, this is because of differences in substrate specificity of the two isoenzymes. 11 In addition, Tpst DKO mice have early postnatal lethality attributable to pulmonary insufficiency of unknown cause. 10 Together, these studies demonstrate that TPST-1 and TPST-2 have distinct but overlapping function.
The role of tyrosine sulfation in protein function has been demonstrated for a number of proteins. 3, 12 For example, sulfation of platelet gp1b␣ and factor VIII is required for efficient binding to thrombin 13 and von Willebrand factor 14 respectively, whereas sulfation of factor V and factor VIII is required for optimal proteolytic processing. 15, 16 In the human system, sulfation of P-selectin glycoprotein ligand-1 (PSGL-1) is required for optimal binding to P-and L-selectin. 4 In addition, sulfation of the N-terminal extracellular domains of certain G protein-coupled receptors, including several chemokine receptors (ie, CCR2, CCR5, CX3CR1), glycoprotein hormone receptors (ie, thyroid stimulating hormone), and others is required for optimal ligand binding and ligand-induced responses in vitro. 3, [5] [6] [7] 17 Mouse orthologs of several of these proteins have been shown to play important roles in mouse models of atherosclerosis, including Psgl-1, Ccr2, Ccr5, and Cx3cr1. Significantly, attenuation of atherosclerosis is observed in ApoE Ϫ/Ϫ mice that are also deficient in Psgl-1, Ccr2, Ccr5, or Cx3cr1. 18 -22 However, the importance of tyrosine sulfation in a com-plex chronic inflammatory disease such as atherosclerosis is unknown.
To explore this question we assessed the development of atherosclerosis in a model in which Tpst DKO hematopoietic progenitors were used to reconstitute hematopoiesis in hyperlipidemic Ldlr Ϫ/Ϫ mice. We observed that TPST deficient progenitors reconstituted hematopoiesis in Ldlr Ϫ/Ϫ recipients and that transplantation had no discernible effect on plasma lipids in Ldlr Ϫ/Ϫ recipients fed either a standard or atherogenic diet. However, we observed a substantial reduction in both lesion size and in the number of macrophages in lesions from Ldlr Ϫ/Ϫ recipients transplanted with Tpst DKO compared to wild-type hematopoietic progenitors.
Methods

Atherosclerosis Model
The generation and characterization of Tpst1 Ϫ/Ϫ ; Tpst2 Ϫ/Ϫ double knockout mice in the 129S6 background was described previously 10, 23 and is discussed in detail in supplemental material (available online at http://atvb.ahajournals.org). Tpst DKO mice have severely impaired postnatal viability. 10 Therefore, fetal livers were used as the source of hematopoietic progenitors. Tpst DKO and wild-type fetuses were generated by timed matings of Tpst1 Ϫ/Ϫ ; Tpst2 ϩ/Ϫ and wild-type males and females, respectively. Fetal livers were harvested at E15.5 and single cell suspensions were prepared by passage through 40 m nylon strainers. Cells were washed in Hank balanced salt solution (HBSS), 10 mmol/L HEPES, and 10% fetal bovine serum and stored at 4°C until transplanted. Tpst DKO fetuses were identified by flow cytometry using PSG2, a monoclonal antibody (mAb) that recognizes sulfotyrosine residues in proteins 23 (see supplemental material). Genotypes were confirmed by PCR for the presence of wild-type and mutant alleles at the Tpst1 and Tpst2 loci. 8, 9 The transplant protocol and timing of experimental end points is illustrated in Figure 1 . Ldlr Ϫ/Ϫ recipients (8-week-old females, B6.129S7-Ldlr tm1Her , Jackson Laboratory, Bar Harbor, Maine) were provided antibiotics in the drinking water (50 mg/L doxycycline, 100 mg/L enrofloxacin) beginning on day Ϫ2. On day 0, animals received 6.5 and 5.5 Gray of ␥-radiation separated by 4 hours and then received 2ϫ10 6 fetal liver cells from wild-type C57BL/6J, wild-type 129S6, or 129S6-Tpst DKO fetuses in 200 L of HBSS, 10 mmol/L HEPES by injection into the retro-orbital venous plexus. These transplant groups are abbreviated as B6-WT3Ldlr, 129-WT3Ldlr, and 129-Tpst DKO3Ldlr, respectively. Animals were fed a normal fat diet (Purina Mills #5053) until day ϩ14 when antibiotics were discontinued and animals were switched to an atherogenic diet (0.15% cholesterol and 21.2% milk fat, Harlan Teklad, #TD88137) for the remaining 16 weeks.
Lipid Analysis
Mice were fasted for 6 hours and blood collected into aprotinin, EDTA, and gentamicin at final concentrations of 1 g/mL, 10 mmol/L, 0.2 mg/mL, respectively. Plasma was prepared by centrifugation. Total and HDL cholesterol were measured using the Cholesterol E kit (WAKO Chemicals) and triglycerides measured using the GPO-Trinder triglyceride kit (Sigma). All assays were performed in triplicate.
Blood Counts
At 18 weeks posttransplant, animals were anesthetized with Avertin (250 mg/kg, i.p.) and exsanguinated. Blood was collected into EDTA and blood counts were performed using a Hemovet HV950FS Hematology Analyzer (Drew Scientific).
Lesion Analysis
Hearts were perfused with 4% paraformaldehyde for 15 minutes, and then the heart and proximal aorta were removed and fixed for 72 hours. Tissues were washed in PBS and embedded in OCT compound and frozen in liquid nitrogen-cooled isopentane. Lesion analysis was performed as previously described. 24 Briefly, serial 10-m sections through the entire aortic valve and sinus were collected on slides so that each slide contained every tenth section. Slides were stained with oil red O and counterstained with hematoxylin. For each section, lesion area (oil red O-reactive area) and the area within the internal elastic lamina were measured from digital images using a digitizing tablet (Model CTE-630BT, Wacom Technology) and ImageJ software. The ratio of lesion area to area within the internal elastic lamina was calculated and averaged over all sections spanning the lesion. The extent of lesion necrosis, defined as the ratio of acellular area to lesion area, was calculated and averaged over 3 midvalve sections.
Macrophages were quantitated using immunofluorescence microscopy in sections immediately adjacent to those stained with oil red O. Frozen sections were blocked in PBS/3% fish gelatin (Ted Pella Inc) for 1 hour. Macrophages were labeled using 25 g/mL of the rat antimouse monocyte/macrophage mAb MOMA-2 (IgG 2b , AbD Serotec) for 1 hour. Sections were washed and incubated in 10 g/mL biotin-conjugated, mouse-adsorbed, rabbit anti-rat IgG (Vector Labs) for 1 hour. After washing, sections were incubated in 10 g/mL Alexa Fluor 488 streptavidin (Invitrogen) for 1 hour, washed, rinsed in H 2 0, and mounted in Vector hard mount containing DAPI. PBS/0.5% gelatin was used for washing and for diluting reagents. Sections stained in parallel using control rat IgG 2b mAb (AbD Serotec) revealed minimal nonspecific immunofluorescence. Fluorescence images were captured using a Photometrics CoolsnapHQ camera coupled to a Nikon Eclipse TE2000-U microscope. All images were captured at the same magnification, filter, and camera settings and were processed using Metamorph software (v6.1, Molecular Devices).
The number of macrophages in the lesions was determined by counting DAPI-stained nuclei within areas immunoreactive with MOMA-2. Cells per mm 2 were calculated by dividing the number of DAPI-stained nuclei within MOMA-2-positive regions by the area of the MOMA-2-positive region. This area was determined by standardizing equally thresholded images to a 200ϫ200 m calibration square. For each animal, the number of cells per mm 2 was determined on 3 midvalve sections collected at 100-m intervals.
To assess whether lesional macrophages were of donor or recipient origin, frozen sections were labeled with MOMA-2 (25 g/mL) and PSG2 (10 g/mL) or equivalent concentrations of control antibodies for 1 hour followed by biotinylated rabbit anti-rat IgG (10 g/mL) for 30 minutes and finally, 10 g/mL streptavidin-CY5 (eBioscience) and antihuman IgG-FITC (10 g/mL) for 30 minutes. Sections were mounted and images captured as above.
Results
Lesion Analysis
Ldlr Ϫ/Ϫ recipients were transplanted with fetal liver hematopoietic progenitors from either Tpst DKO or wild-type fetuses in the 129S6 background or wild-type C57BL/6J fetuses. Eighteen weeks after transplant, atherosclerotic lesions were evident in all transplant groups. In control B6-WT3Ldlr and 129-WT3Ldlr animals, the lesions encompassed 24.2Ϯ3.0% (meanϮSEM, nϭ6) and 19.2Ϯ2.7% (nϭ10) of the area within the internal elastic lamina, respectively ( Figure 2A and supplemental Figure I ). In contrast, the lesions in 129-Tpst DKO3Ldlr animals encompassed only 6.2Ϯ0.9% (nϭ10) of the area within the internal elastic lamina, a Ϸ3-fold reduction in lesion size ( Figure 2B ). Lesion size in the 3 groups was significantly different (PϽ0.0001, 1-way ANOVA). Posthoc t testing showed that lesions in the 129-Tpst DKO3Ldlr group were smaller compared to both the B6-WT3Ldlr (PϽ0.0001) and 129-WT3Ldlr (Pϭ0.0003) groups. However, lesion size was not different between B6-WT3Ldlr and 129-WT3Ldlr mice (Pϭ0.25).
We also quantitated the extent of necrosis within the atherosclerotic lesions. Necrosis was evident in lesions from all transplanted groups and the total necrotic area was reduced in 129-Tpst DKO3Ldlr lesions compared to the control groups. However, there were no statistical differences in the ratio of necrotic area to lesion area between transplant groups ( Figure 2C ; Pϭ0.32, 1-way ANOVA). The number of lesional macrophages was determined in 3 midvalve sections from 5 animals in each experimental group at 18 weeks posttransplant. Accumulation of macrophages was evident in all transplanted groups ( Figure 2E ). In control B6-WT3Ldlr and 129-WT33Ldlr animals, the number of macrophages in lesions was 4558Ϯ917 and 5447Ϯ758 cells/mm 2 , respectively (meanϮSEM). In contrast, we observed only 2232Ϯ168 cells/mm 2 in the lesions in 129-Tpst DKO3Ldlr animals ( Figure 2D ). The number of macrophages in the 3 Figure I ) and stained with oil red O. The midvalve sections shown represent lesions nearest to the mean lesion size for each transplant group. B, The ratio of the lesion area to the area within the internal elastic lamina was calculated and averaged over the entire lesion. MeanϮSEM (nϭ10). C, Necrotic area was averaged over 3 midvalve sections. MeanϮSEM (nϭ10). D, Lesional macrophages were quantitated using immunofluorescence microscopy on 3 midvalve sections adjacent to those used to quantitate lesion size. MeanϮSEM (nϭ5). Datasets were subjected to 1-way ANOVA, and statistical differences between individual groups were assessed by posthoc testing using a Student's 2-tailed t test with unequal sample variance. E, Representative images of immunofluorescence analyses used to quantitate macrophages in lesions from B6-WT3Ldlr (left), 129-WT3Ldlr (middle), and 129-Tpst DKO3Ldlr (right) animals. Macrophages (green) and nuclei (blue) were identified using the MOMA-2 and DAPI, respectively. Barsϭ400 m.
groups was statistically different (Pϭ0.018, 1-way ANOVA). Posthoc t testing showed that the number of macrophages in the 129-Tpst DKO3Ldlr group was smaller compared to the B6-WT3Ldlr (Pϭ0.0372) and the 129-WT3Ldlr group (Pϭ0.0033) group. However, the number of macrophages was not different between B6-WT3Ldlr and 129-WT3Ldlr mice (Pϭ0.48).
To assess whether the attenuation of lesion development was specific for the aortic root, en face oil red O staining of the abdominal aortas from 4 animals in each transplant group was performed focusing on the ostia of the intercostal arteries. We observed a similar degree of attenuation of lesion development in the 129-Tpst DKO3Ldlr group compared to the control groups as observed in the aortic root (supplemental Figure III) .
Lipid Analysis
The impact of the transplants on lipid metabolism was assessed by measuring total cholesterol, HDL cholesterol, and triglyceride levels at 2 weeks posttransplant while mice were on a normal chow diet and then again at 6 and 14 weeks posttransplant while on an atherogenic diet (Table) . No statistical differences were observed between the groups at 2 weeks posttransplant while on normal chow. As anticipated, total cholesterol, HDL cholesterol, and triglyceride levels increased in all 3 groups after 4 and 12 weeks on the atherogenic diet. However, there were still no statistical differences between groups.
Hematopoietic Reconstitution
Blood counts were performed 18 weeks posttransplant. Total leukocyte, lymphocyte, monocyte, and platelet counts were not statistically different between the transplant groups (supplemental Table I ). However, neutrophil and erythrocyte counts were statistically different as assessed by 1-way ANOVA. Posthoc t testing showed that neutrophil counts were higher in the 129-WT3Ldlr group compared to B6-WT3Ldlr groups (Pϭ0.022). In addition, erythrocyte counts were higher in the B6-WT3Ldlr compared to the 129-Tpst DKO3Ldlr (Pϭ0.003). Nevertheless, all parameters were within the normal range.
To assess the efficiency of reconstitution of Tpst DKO hematopoiesis in Ldlr Ϫ/Ϫ mice, the percentage of circulating PSG2-positive leukocytes was determined at 18 weeks posttransplant. Analysis of the leukocyte population from 129-WT3Ldlr mice showed that virtually all the circulating leukocytes were PSG2-positive (Figure 3, top) . However, fluorescence (FL1) histograms of cells stained with isotype control mAb and PSG2 are not completely resolved. Thus, the valley between the 2 FL1 histograms was used to define the FL1 threshold for quantitating the percentage of PSG2-positive cells in 129-Tpst DKO3Ldlr mice (Figure 3 , bottom). It should be noted that this definition might underestimate the degree of donor hematopoiesis in mice transplanted with Tpst DKO progenitors. Nevertheless, 82.4Ϯ1.9% (meanϮSEM, nϭ10) of the total leukocytes displayed a PSG2 lo phenotype and thus were of donor origin. By the same criteria, 92.9Ϯ1.1 (meanϮSEM, nϭ10) of the total leukocytes in 129-WT3Ldlr mice were PSG2 hi . Taken together, these data confirm efficient reconstitution of Tpst DKO hematopoiesis in the Ldlr Ϫ/Ϫ recipients at the time of lesion analysis. Fasting plasma total cholesterol, HDL cholesterol, and triglycerides were determined 2 weeks posttransplant while mice were on normal chow and 6 and 14 weeks posttransplant while on an atherogenic diet. MeanϮSEM (nϭ10) of assays performed in triplicate. Statistical significances between the 3 experimental groups at each time point were determined by single factor ANOVA. To assess whether the macrophages in the lesions in 129-Tpst DKO3Ldlr mice were donor or recipient in origin, immunofluorescence staining was performed using MOMA-2 and PSG2 antibodies. We observed clear colocalization of MOMA-2 and PSG2 staining in 129-Tpst DKO3Ldlr lesions (Figure 4 ), indicating that some of the macrophages in these lesions were of recipient and not donor origin.
Psgl-1 and Chemokine Receptor Expression
To assess whether the absence of TPSTs in hematopoietic cells affects surface expression of Psgl-1 and a panel of chemokine receptors we examined peripheral blood leukocyte in B6.SJL mice (CD45.1 ϩ ) transplanted with 15.5-dpc fetal liver cells from Tpst DKO mice (CD45.2 ϩ ) or wild-type 129S6 mice by flow cytometry. In 3 independent comparisons 20 to 24 weeks posttransplant, surface expression of Psgl-1, Ccr5, and Cx3cr1 was indistinguishable in the 129-Tpst DKO3 B6.SJL and 129-WT3 B6.SJL groups (supplemental Figure IIA) . At the time of analysis, all recipients had normal blood counts, and 90% to 95% of circulating leukocytes were of donor (CD45.2 ϩ ) origin (data not shown). We also examined thymocytes from a rare 2-week-old Tpst DKO survivor and a sex-and age-matched wild-type mouse. We observed no differences in the expression of Psgl-1, Ccr6, Ccr7, D6, Cxcr2, and Cxcr4 (supplemental Figure IIB) .
Sulfotyrosine Analysis
It is widely assumed that mouse Psgl-1 and many chemokine receptors are tyrosine-sulfated like their human counterparts. However, this has never been experimentally verified. To address the question, a direct biochemical analysis of metabolically labeled, purified native mouse Psgl-1 and recombinant mouse Cx3cr1 expressed in mouse pre-B L1.2 cells was performed as described in supplemental material. This analysis unambiguously demonstrates that both molecules are tyrosine-sulfated ( Figure 5 ).
Discussion
Atherosclerosis is a chronic inflammatory disease of the arterial wall initiated by injury of the vascular endothelium leading to endothelial dysfunction and subsequent intramural accumulation of oxidized LDL. [25] [26] [27] [28] This is followed by the elaboration of signaling molecules and induction of adhesion receptors that promote recruitment of monocytes into developing lesions, which subsequently mature into lipid-laden foam cells. A compelling body of evidence indicates that recruitment of monocytes is a dominant factor in the initiation and progression of atherosclerosis. 29 Genetic studies in mice indicate that Ccr2, Ccr5, Cx3cr1, and the adhesion molecule Psgl-1, which are all expressed on monocytes, are proatherogenic and play important roles in monocyte recruitment in atherosclerosis. 18 -22,30,31 Furthermore, in vitro studies have shown that human CCR2B, CCR5, CX3CR1, and PSGL-1 contain sulfotyrosine residues that are required for optimal function in vitro. 4 -7 However, at present it is not known whether these proteins are sulfated in the mouse system or whether sulfation of these proteins is important for their optimal function in vivo.
Based on these data, we examined the effect of hematopoietic deficiency of TPST activity on the development of atherosclerosis in a model in which Tpst DKO hematopoietic progenitor cells were used to reconstitute hematopoiesis in Ldlr Ϫ/Ϫ mice. We observed a 68% reduction in the size of aortic root lesions in recipients transplanted with TPSTdeficient progenitors compared to 129S6 wild-type controls. The reduction in lesion size was accompanied by a 2-to 3-fold reduction in the number of lesional macrophages. As expected, attenuated lesions in 129-Tpst DKO3Ldlr animals contained smaller necrotic areas. However, no differences in the ratio of necrotic area to lesion size were apparent between the experimental and control groups. This suggests that although TPST deficiency in macrophages attenuates monocyte/macrophage recruitment and/or retention, it does not perturb phagocytic clearance of apoptotic/necrotic cells.
To address potential mechanism(s) for the reduction in lesion size, factors known to be important in lesion development or progression were assessed. Lipid metabolism and especially LDL cholesterol levels are directly correlated with development of atherosclerosis. However, we observed no differences in cholesterol or triglyceride levels between the experimental groups. Thus, TPST deficiency in the hematopoietic compartment does not affect overall lipid homeostasis in the Ldlr Ϫ/Ϫ recipients, and the reduction in lesion size was not attributable to reduced exposure of the endothelium to plasma-derived lipids. Monocyte recruitment is the major cellular event to influence lesion progression and the level of circulating monocytes can directly impact lesion development. 29 However, we observed no differences in monocyte counts between the experimental and control groups at 18 weeks posttransplant. Reduced lesion size in 129-Tpst DKO3Ldlr mice may be attributable to reduced expression of chemokine receptors or adhesion molecules on TPSTdeficient hematopoietic cells resulting in decreased recruitment of monocytes into developing lesions. However, we observed that expression of a panel of chemokine receptors and Psgl-1 on Tpst DKO hematopoietic cells was normal. This finding is consistent with previous observations that inhibition of tyrosine sulfation has no impact on the secretion or surface expression of a variety of tyrosine-sulfated proteins, including chemokine receptors. 3, 5 In our experimental group, Tpst DKO fetal liver cells from 129S6 donors were used to reconstitute hematopoiesis in Ldlr Ϫ/Ϫ recipients in the B6 background. However, no difference in any experimental end point was observed between the controls in which wild-type 129S6 or C57BL/6J mice were used as donors. Therefore, the reduction in lesion size in the 129-Tpst DKO3Ldlr group is not related to the difference in genetic background between donor and recipient.
In this study, we used the antisulfotyrosine mAb PSG2 to identify Tpst DKO donor fetuses and to assess the degree of chimerism in mice transplanted with Tpst DKO progenitors. In the 129-Tpst DKO3Ldlr mice at 18 weeks posttransplant, we found that on average Ϸ82% of the total leukocytes were PSG2 lo and thus were of donor origin. This led us to ask whether the lesional macrophages in these mice were donor or recipient in origin. Immunofluorescence staining showed colocalization of PSG2 and MOMA-2 staining in 129-Tpst DKO3Ldlr lesions. This indicates that at least some of the lesion development observed in 129-Tpst DKO3Ldlr mice may be attributable to residual recipient hematopoiesis, suggesting that lesion development might have been further attenuated if a higher level of chimerism had been achieved. Alternatively, colocalization of PSG2 and MOMA-2 in lesions may be a reflection of close association of sulfated plasma proteins or membrane microparticles derived from the recipient. It is also possible, but very unlikely, that this colocalization reflects in-trans sulfation of donor macrophage proteins by TPSTs derived from recipient cells.
The 68% reduction in aortic root lesion area we observed is greater than that reported in ApoE Ϫ/Ϫ ; Cx3cr1 Ϫ/Ϫ (32%), 22 
ApoE
Ϫ/Ϫ ; Selplg Ϫ/Ϫ (Ϸ 40%), 18 and ApoE Ϫ/Ϫ ; Ccr5 Ϫ/Ϫ double knockouts (Ϸ 50%), 21 but comparable to that observed in ApoE Ϫ/Ϫ ; Ccr2 Ϫ/Ϫ double knockouts (Ϸ 60%). 19, 20 However, the relative impact that defective sulfation of these proteins has in lesion attenuation is unclear. Nevertheless, it is reasonable to conclude that the dramatic reduction in aortic were metabolically labeled and Cx3cr1 and Psgl-1 immunoprecipitated using HPC4 or 4RA10, respectively, or isotype control mAbs. Immunoprecipitates were electrophoresed under nonreducing (Cx3cr1) and reducing conditions (Psgl-1) and electroblotted onto PVDF membranes. Membranes were immunoblotted (left) or subjected to autoradiography (middle). Bands (arrows) were excised, subjected to alkaline hydrolysis, and hydrolysates were subjected to thin layer electrophoresis (right). Plates were exposed to film to reveal radiolabeled sulfoamino acids (lanes 1) and sprayed with ninhydrin to reveal internal sulfoamino acid standards (lanes 2).
root lesion area observed is attributable to defective sulfation of multiple proteins involved in monocyte recruitment and/or retention, including Psgl-1, Cx3cr1 ( Figure 5 ) as well as Ccr2, Ccr5, and other proteins yet to be identified.
Our findings suggest that strategies for treatment and prevention of atherosclerosis might be developed based either on drugs that inhibit the interaction between specific tyrosinesulfated proteins and their cognate ligand(s) or ones that inhibit TPST activity. Targeting a specific receptor/ligand interaction might be favored if that interaction plays the dominant role in development of atherosclerosis. However, as discussed above, current data argue that the reduction in atherosclerosis we observe is attributable to defective sulfation of multiple proteins. In this circumstance, inhibition of TPST activity may be the preferred approach. However, potential off-target effects may limit the viability of this approach given the number of tyrosine-sulfated proteins both known and unknown.
In conclusion, posttranslational tyrosine sulfation of protein(s) in hematopoietic cells has a major impact on the development of atherosclerosis in hyperlipidemic Ldlr Ϫ/Ϫ mice. Our findings represent the first direct evidence that protein-tyrosine sulfation plays a key role in the development of a common and clinically important inflammatory disorder. 
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